{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:14:38Z","timestamp":1790255678300,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T00:00:00Z","timestamp":1453161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1038\/mp.2015.217","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T04:18:17Z","timestamp":1453177097000},"page":"1504-1510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0124-0634","authenticated-orcid":false,"given":"N","family":"Yoshimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Futamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Iwayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Sellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"P\u00e5lsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kakumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ohgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Land\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,19]]},"reference":[{"key":"BFmp2015217_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra035354","volume":"351","author":"RH Belmaker","year":"2004","unstructured":"Belmaker RH . Bipolar disorder. New Engl J Med 2004; 351: 476\u2013486.","journal-title":"New Engl J Med"},{"key":"BFmp2015217_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrneurol.2009.117","volume":"5","author":"E Taylor","year":"2009","unstructured":"Taylor E . Managing bipolar disorders in children and adolescents. Nat Rev Neurol 2009; 5: 484\u2013491.","journal-title":"Nat Rev Neurol"},{"key":"BFmp2015217_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","volume":"70","author":"C Crump","year":"2013","unstructured":"Crump C, Sundquist K, Winkleby MA, Sundquist J . Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 2013; 70: 931\u2013939.","journal-title":"JAMA Psychiatry"},{"key":"BFmp2015217_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bdi.12165","volume":"16","author":"K Kleine-Budde","year":"2014","unstructured":"Kleine-Budde K, Touil E, Moock J, Bramesfeld A, Kawohl W, Rossler W . Cost of illness for bipolar disorder: a systematic review of the economic burden. Bipolar Disord 2014; 16: 337\u2013353.","journal-title":"Bipolar Disord"},{"key":"BFmp2015217_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00127-013-0724-9","volume":"48","author":"M Ekman","year":"2013","unstructured":"Ekman M, Granstrom O, Omerov S, Jacob J, Landen M . The societal cost of bipolar disorder in Sweden. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 1601\u20131610.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"BFmp2015217_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jad.2010.08.030","volume":"129","author":"SC Dilsaver","year":"2011","unstructured":"Dilsaver SC . An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J Affect Disord 2011; 129: 79\u201383.","journal-title":"J Affect Disord"},{"key":"BFmp2015217_CR7","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","volume":"381","author":"N Craddock","year":"2013","unstructured":"Craddock N, Sklar P . Genetics of bipolar disorder. Lancet 2013; 381: 1654\u20131662.","journal-title":"Lancet"},{"key":"BFmp2015217_CR8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1038\/npp.2014.81","volume":"39","author":"J Jakobsson","year":"2014","unstructured":"Jakobsson J, Bjerke M, Ekman CJ, Sellgren C, Johansson AG, Zetterberg H et al. Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients. Neuropsychopharmacology 2014; 39: 2349\u20132356.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015217_CR9","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1600-0447.2010.01586.x","volume":"122","author":"CJ Ekman","year":"2010","unstructured":"Ekman CJ, Lind J, Ryden E, Ingvar M, Landen M . Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis. Acta Psychiatr Scand 2010; 122: 507\u2013515.","journal-title":"Acta Psychiatr Scand"},{"key":"BFmp2015217_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/hmg\/ddi022","volume":"14","author":"K Iwamoto","year":"2005","unstructured":"Iwamoto K, Bundo M, Kato T . Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 2005; 14: 241\u2013253.","journal-title":"Hum Mol Genet"},{"key":"BFmp2015217_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.tins.2008.07.007","volume":"31","author":"T Kato","year":"2008","unstructured":"Kato T . Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'? Trends Neurosci 2008; 31: 495\u2013503.","journal-title":"Trends Neurosci"},{"key":"BFmp2015217_CR12","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/sj.npp.1301671","volume":"33","author":"JA Quiroz","year":"2008","unstructured":"Quiroz JA, Gray NA, Kato T, Manji HK . Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008; 33: 2551\u20132565.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015217_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2011.01.025","volume":"45","author":"C Konradi","year":"2012","unstructured":"Konradi C, Sillivan SE, Clay HB . Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 2012; 45: 37\u201347.","journal-title":"Neurobiol Dis"},{"key":"BFmp2015217_CR14","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1017\/S1461145713000096","volume":"17","author":"AC Andreazza","year":"2014","unstructured":"Andreazza AC, Young LT . The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment. Int J Neuropsychopharmacol 2014; 17: 1039\u20131052.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp2015217_CR15","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1517\/14728222.2014.940893","volume":"18","author":"RT de Sousa","year":"2014","unstructured":"de Sousa RT, Machado-Vieira R, Zarate CA Jr, Manji HK . Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin Ther Targets 2014; 18: 1131\u20131147.","journal-title":"Expert Opin Ther Targets"},{"key":"BFmp2015217_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","volume":"134","author":"E Holmes","year":"2008","unstructured":"Holmes E, Wilson ID, Nicholson JK . Metabolic phenotyping in health and disease. Cell 2008; 134: 714\u2013717.","journal-title":"Cell"},{"key":"BFmp2015217_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nbd.2009.02.019","volume":"35","author":"MP Quinones","year":"2009","unstructured":"Quinones MP, Kaddurah-Daouk R . Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 2009; 35: 165\u2013176.","journal-title":"Neurobiol Dis"},{"key":"BFmp2015217_CR18","doi-asserted-by":"publisher","first-page":"10761","DOI":"10.1073\/pnas.1402663111","volume":"111","author":"SK Davies","year":"2014","unstructured":"Davies SK, Ang JE, Revell VL, Holmes B, Mann A, Robertson FP et al. Effect of sleep deprivation on the human metabolome. Proc Natl Acad Sci USA 2014; 111: 10761\u201310766.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2015217_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/sj.mp.4002130","volume":"14","author":"MJ Lan","year":"2009","unstructured":"Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P et al. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 2009; 14: 269\u2013279.","journal-title":"Mol Psychiatry"},{"key":"BFmp2015217_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1471-4159.1981.tb01608.x","volume":"36","author":"TL Perry","year":"1981","unstructured":"Perry TL, Hansen S, Gandham SS . Postmortem changes of amino compounds in human and rat brain. J Neurochem 1981; 36: 406\u2013410.","journal-title":"J Neurochem"},{"key":"BFmp2015217_CR21","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","volume":"62","author":"K Hashimoto","year":"2007","unstructured":"Hashimoto K, Sawa A, Iyo M . Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 2007; 62: 1310\u20131316.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015217_CR22","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1021\/ac900675k","volume":"81","author":"T Soga","year":"2009","unstructured":"Soga T, Igarashi K, Ito C, Mizobuchi K, Zimmermann HP, Tomita M . Metabolomic profiling of anionic metabolites by capillary electrophoresis mass spectrometry. Anal Chem 2009; 81: 6165\u20136174.","journal-title":"Anal Chem"},{"key":"BFmp2015217_CR23","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/pr034020m","volume":"2","author":"T Soga","year":"2003","unstructured":"Soga T, Ohashi Y, Ueno Y, Naraoka H, Tomita M, Nishioka T . Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res 2003; 2: 488\u2013494.","journal-title":"J Proteome Res"},{"key":"BFmp2015217_CR24","doi-asserted-by":"publisher","first-page":"e73814","DOI":"10.1371\/journal.pone.0073814","volume":"8","author":"H Kuwabara","year":"2013","unstructured":"Kuwabara H, Yamasue H, Koike S, Inoue H, Kawakubo Y, Kuroda M et al. Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study. PLoS One 2013; 8: e73814.","journal-title":"PLoS One"},{"key":"BFmp2015217_CR25","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1038\/tp.2014.19","volume":"4","author":"S Koike","year":"2014","unstructured":"Koike S, Bundo M, Iwamoto K, Suga M, Kuwabara H, Ohashi Y et al. A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study. Transl Psychiatry 2014; 4: e379.","journal-title":"Transl Psychiatry"},{"key":"BFmp2015217_CR26","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00702-009-0300-3","volume":"116","author":"E Ryden","year":"2009","unstructured":"Ryden E, Johansson C, Blennow K, Landen M, Lower CSF . HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD. J Neural Transm 2009; 116: 1667\u20131674.","journal-title":"J Neural Transm"},{"key":"BFmp2015217_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.euroneuro.2014.11.001","volume":"25","author":"E Palsson","year":"2015","unstructured":"Palsson E, Jakobsson J, Sodersten K, Fujita Y, Sellgren C, Ekman CJ et al. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls. Eur Neuropsychopharmacol 2015; 25: 133\u2013140.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFmp2015217_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0006-3223(03)00165-3","volume":"53","author":"GS Sachs","year":"2003","unstructured":"Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 2003; 53: 1028\u20131042.","journal-title":"Biol Psychiatry"},{"key":"BFmp2015217_CR29","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22\u201333.","journal-title":"J Clin Psychiatry"},{"key":"BFmp2015217_CR30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption\u2014II. Addiction 1993; 88: 791\u2013804.","journal-title":"Addiction"},{"key":"BFmp2015217_CR31","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/schbul\/sbp106","volume":"35","author":"S Kim","year":"2009","unstructured":"Kim S, Webster MJ . Postmortem brain tissue for drug discovery in psychiatric research. Schizophr Bull 2009; 35: 1031\u20131033.","journal-title":"Schizophr Bull"},{"key":"BFmp2015217_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/npp.2009.151","volume":"35","author":"S Kim","year":"2010","unstructured":"Kim S, Webster MJ . The Stanley neuropathology consortium integrative database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology 2010; 35: 473\u2013482.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp2015217_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0920-9964(99)00192-9","volume":"44","author":"EF Torrey","year":"2000","unstructured":"Torrey EF, Webster M, Knable M, Johnston N, Yolken RH . The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr Res 2000; 44: 151\u2013155.","journal-title":"Schizophr Res"},{"key":"BFmp2015217_CR34","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/00401706.1974.10489157","volume":"16","author":"DM Allen","year":"1974","unstructured":"Allen DM . The relationship between variable selection and data augmentation, and a method for prediction. Technometrics 1974; 16: 125\u2013127.","journal-title":"Technometrics"},{"key":"BFmp2015217_CR35","volume-title":"Subset Selection in Regression","author":"AJ Miller","year":"1974","unstructured":"Miller AJ . Subset Selection in Regression. Chapman and Hall, CRC: Boca Raton, FL, 1974."},{"key":"BFmp2015217_CR36","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1097\/CCM.0b013e318218a05b","volume":"39","author":"S Hunziker","year":"2011","unstructured":"Hunziker S, Bivens MJ, Cocchi MN, Miller J, Salciccioli J, Howell MD et al. International validation of the out-of-hospital cardiac arrest score in the United States. Crit Care Med 2011; 39: 1670\u20131674.","journal-title":"Crit Care Med"},{"key":"BFmp2015217_CR37","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1182\/blood-2008-04-149070","volume":"113","author":"M Wadelius","year":"2009","unstructured":"Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori MJ, Bumpstead S et al. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 2009; 113: 784\u2013792.","journal-title":"Blood"},{"key":"BFmp2015217_CR38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 1995; 57: 289\u2013300.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"BFmp2015217_CR39","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10534-006-9047-6","volume":"20","author":"WH Tong","year":"2007","unstructured":"Tong WH, Rouault TA . Metabolic regulation of citrate and iron by aconitases: role of iron-sulfur cluster biogenesis. Biometals 2007; 20: 549\u2013564.","journal-title":"Biometals"},{"key":"BFmp2015217_CR40","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1172\/JCI67266","volume":"123","author":"AS McKenney","year":"2013","unstructured":"McKenney AS, Levine RL . Isocitrate dehydrogenase mutations in leukemia. J Clin Invest 2013; 123: 3672\u20133677.","journal-title":"J Clin Invest"},{"key":"BFmp2015217_CR41","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-13-0083","volume":"3","author":"RA Cairns","year":"2013","unstructured":"Cairns RA, Mak TW . Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities. Cancer Discov 2013; 3: 730\u2013741.","journal-title":"Cancer Discov"},{"key":"BFmp2015217_CR42","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1038\/ng.223","volume":"40","author":"DT Hartong","year":"2008","unstructured":"Hartong DT, Dange M, McGee TL, Berson EL, Dryja TP, Colman RF . Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle. Nat Genet 2008; 40: 1230\u20131234.","journal-title":"Nat Genet"},{"key":"BFmp2015217_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jad.2015.01.026","volume":"175","author":"JA Dudley","year":"2015","unstructured":"Dudley JA, Lee JH, Durling M, Strakowski SM, Eliassen JC . Age-dependent decreases of high energy phosphates in cerebral gray matter of patients with bipolar I disorder: a preliminary phosphorus-31 magnetic resonance spectroscopic imaging study. J Affect Disord 2015; 175: 251\u2013255.","journal-title":"J Affect Disord"},{"key":"BFmp2015217_CR44","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/archpsyc.61.3.300","volume":"61","author":"C Konradi","year":"2004","unstructured":"Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S . Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 2004; 61: 300\u2013308.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2015217_CR45","first-page":"189","volume":"31","author":"X Sun","year":"2006","unstructured":"Sun X, Wang JF, Tseng M, Young LT . Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 2006; 31: 189\u2013196.","journal-title":"J Psychiatry Neurosci"},{"key":"BFmp2015217_CR46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2010.22","volume":"67","author":"AC Andreazza","year":"2010","unstructured":"Andreazza AC, Shao L, Wang JF, Young LT . Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 2010; 67: 360\u2013368.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2015217_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0165-0327(94)90116-3","volume":"31","author":"T Kato","year":"1994","unstructured":"Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T . Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 1994; 31: 125\u2013133.","journal-title":"J Affect Disord"},{"key":"BFmp2015217_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pscychresns.2007.08.004","volume":"162","author":"JD Port","year":"2008","unstructured":"Port JD, Unal SS, Mrazek DA, Marcus SM . Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study. Psychiatry Res 2008; 162: 113\u2013121.","journal-title":"Psychiatry Res"},{"key":"BFmp2015217_CR49","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","volume":"61","author":"SR Dager","year":"2004","unstructured":"Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004; 61: 450\u2013458.","journal-title":"Arch Gen Psychiatry"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2015217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2015217","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2015217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:54:59Z","timestamp":1748739299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2015217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,19]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["BFmp2015217"],"URL":"https:\/\/doi.org\/10.1038\/mp.2015.217","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726084834.793526786","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,19]]},"assertion":[{"value":"10 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N Yoshimi, Dr T Futamura, K Kakumoto, and Y Ohgi are employees of Otsuka Pharmaceutical (Tokyo, Japan). N Yoshimi, T Futamura, Y Iwayama, T Yoshikawa, M Land\u00e9n and K Hashimoto are inventors of the patent entitled \u2018Methods of diagnosing bipolar disorders and screening for therapeutic compounds\u2019. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}